January 31, 2015 5:48 AM ET

Professional Services

Company Overview of Ability Biomedical Corp.

Company Overview

Ability Biomedical Corporation develops chemokine-based therapeutics for treatment of Multiple Sclerosis (MS), as well as acute spinal cord and brain injuries. The company is researching the efficacy of injectable interferon-inducible protein 10 (IP-10) antibody in alleviating and improving symptoms of multiple sclerosis, and eliminating physical deterioration post-spinal cord injury. Ability Biomedical was founded in 2002 and is based in Vancouver, Canada. As of August 2004, Ability Biomedical Corporation was a subsidiary of Medarex Inc. Later, it operates as a subsidiary of Bristol-Myers Squibb Company.

1055 West Georgia Street

Suite 2600

Royal Centre

Vancouver, BC V6E 3R5


Founded in 2002





Key Executives for Ability Biomedical Corp.

Chief Science Officer and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Drake International Inc. Americas
The Verriez Group Inc. Americas
Kovasys Inc. Americas
ALS Chemex Labs, Ltd. Americas
Colas Moreira Kazandjian Zikovsky, LLP Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ability Biomedical Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.